ANKRD1 | Ankyrin repeat domain 1 (cardiac muscle) | Disease related genes Predicted intracellular proteins
| | | | | Tissue enriched |
MYOM2 | Myomesin 2 | Predicted intracellular proteins
| | | | | Group enriched |
TNNC1 | Troponin C type 1 (slow) | Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
UNC45B | Unc-45 homolog B (C. elegans) | Predicted intracellular proteins
| | | | | Group enriched |
SYNPO2L | Synaptopodin 2-like | Cytoskeleton related proteins Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
LDB3 | LIM domain binding 3 | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
MYO18B | Myosin XVIIIB | Predicted intracellular proteins
| | | | | Group enriched |
ANKRD2 | Ankyrin repeat domain 2 (stretch responsive muscle) | Predicted intracellular proteins
| | | | | Group enriched |
CAV3 | Caveolin 3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
FGF1 | Fibroblast growth factor 1 (acidic) | Cancer-related genes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Group enriched |
FHL2 | Four and a half LIM domains 2 | Predicted intracellular proteins
| | | | | Group enriched |
PDE4DIP | Phosphodiesterase 4D interacting protein | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Group enriched |
POPDC3 | Popeye domain containing 3 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
SGCG | Sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | Cytoskeleton related proteins Disease related genes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
AK1 | Adenylate kinase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Group enriched |
SORBS2 | Sorbin and SH3 domain containing 2 | Predicted intracellular proteins
| | | | | Group enriched |
ALPK2 | Alpha-kinase 2 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
CDH2 | Cadherin 2, type 1, N-cadherin (neuronal) | CD markers Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MASP1 | Mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
NES | Nestin | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PDE3A | Phosphodiesterase 3A, cGMP-inhibited | Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
PKP2 | Plakophilin 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
PPFIA4 | Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |